Product Images Enoxaparin Sodium

The text is describing a chemical formula containing OR and NHR, along with SOsNa and COCHs. However, there is not enough information to determine what the formula is used for or what properties it has.*

This is a description of Enoxaparin Sodium Injection, a medication for subcutaneous injection with a dosage of 30 mg per 0.3 mL. The medication is distributed in single-dose syringes with an automatic safety device by Cardinal Health. The syringes are sterile and derived from porcine intestinel mucosa in Water for Injection. The package is intended for institutional use only and should be stored at temperatures between 20° G - 25° C (66° F - 77° F). The manual provides precise dosage information and instructions for safe administration. The safety system must only be activated after removing the needle from the patient's skin and the needle shield should not be replaced after injection.*

This is a product information for Enoxaparin Sodium Injection, USP, a subcutaneous injection for institutional use only. It is available in single-dose syringes with automatic safety devices that are not child-resistant. The product insert must be referred to for dosage and administration, warnings, precautions, directions for use, and prescribing information. The product must be stored at controlled room temperature, and the safety system is activated after injecting patients using a standard technique by firmly pushing the plunger rod away from oneself while orienting it downwards to avoid any minimal splatter of fluid.*

This is a product description of Enoxaparin sodium injection, which is contained in single-dose syringes. The syringes have an automatic safety device and are for subcutaneous injection only. Each syringe contains 60 mg of the injection, and each 0.025mL graduation equals 2.5mg of the injection. The product insert contains dosage information, directions for use, prescribing information, precautions, and warnings. The injection is stored at 20-25 °C, and the package is not child-resistant and intended for institutional use only. The manufacturer is Gland Pharma Ltd., and the product is distributed by Cardinal Health. The directions for use involve removing the needle shield, adjusting the dose, injecting using standard technique, activating the safety system by firmly pushing the plunger rod, and then disposing of the syringe. The activation of the safety system must be done only after removing the needle from the patient's skin.*

Enoxaparin Sodium Injection is a subcutaneous injection used to prevent or treat blood clots. It comes in a single-dose syringe with automatic safety devices that are used for subcutaneous injection. Each syringe contains 80mg enoxaparin sodium injection, derived from porcine intestinal mucosa in Water for Injection. It is advised to read the product insert for dosage information, directions for use, prescribing information, precautions, and warnings. Graduation of each 0.025 mL equals 2.5mg enoxaparin sodium injection. It should be stored at 20°C-25°C (68°F-77°F). This unit dose package is not child-resistant and is only intended for institutional use. The manufacturer of the injection is Gland Pharma Ltd in Hyderabad, India, and it's manufactured for Apotex Corp in Weston, Florida. The safety device automatically covers the needle following injection avoiding any risk of injury. After injection, the device should be activated and then disposed of in the nearest sharps container. The safety system can only be activated after emptying the syringe, and not before removing the needle from the patient's skin. The safety system may cause minimal splatter, hence it is advised to activate it downwards, away from yourself and others.*

Enoxaparin Sodium Injection, USP is a medicine used for subcutaneous injection, each containing 100mg enoxaparin sodium injection. It comes in eight pre-loaded single-dose syringes with automatic safety devices, derived from porcine intestinal mucosa in water for injection. Each syringe includes dosage information, directions for use, and storage instructions. This medicine should be stored at the temperature of 20°C to 25°C. The syringe should be disposed of immediately in the nearest sharps container after use. The safety system should be activated only after the needle is withdrawn from the patient's skin, and not be sterilized. This medicine is manufactured by Gland Pharma Ltd. and distributed by Cardinal Health. It is exclusively for institutional use only and comes with warnings to keep out of the reach of children.*